« Older Entries
Newer Entries »
FoRx Therapeutics AG Raises EUR 10 Million Seed Round
Thursday, April 23rd, 2020
First Company to Develop a Pipeline of Drugs Targeting DNA Replication Stress for Cancer
Seasoned Biotech Executive Colin Goddard Joins as Executive Chairman
Basel, Switzerland, 22 April, 2020 – FoRx [...]
COVID-19 – Perspective from a Biotech Investor Part 2
Thursday, April 23rd, 2020
by Geraldine O'Keeffe and Mark Wegter
Amsterdam, April 23, 2020 - It has been 5 weeks since we published our first note on the COVID-19 pandemic and summarized the the unprecedented medical and scientif [...]
Immunic, Inc. Announces Pricing of $15 Million Financing
Thursday, April 23rd, 2020
NEW YORK, April 23, 2020 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and au [...]
Binx aims to capture a milestone in STI testing technology
Wednesday, April 22nd, 2020
Three months ago Binx Health, a Boston-based biotech firm founded in 2005, started taking preorders for its flagship product, the Io, which has been in development for over a decade. It’s a deceptively simple piece [...]
1
Wednesday, April 8th, 2020
1
[...]
Zealand Pharma submits New Drug Application
Tuesday, March 31st, 2020
Zealand Pharma submits New Drug Application to the U.S. Food and Drug Administration for the Dasiglucagon HypoPal® Rescue Pen for treatment of severe hypoglycemia
The Dasiglucagon HypoPal® Rescue Pen New Dru [...]
« Older Entries
Newer Entries »
Follow us
